Top

Published in:

Open Access 01-12-2013 | Review

Developmental maturation of astrocytes and pathogenesis of neurodevelopmental disorders

Authors: Yongjie Yang, Haruki Higashimori, Lydie Morel

Published in: Journal of Neurodevelopmental Disorders | Issue 1/2013

Abstract

Recent studies have implicated potentially significant roles for astrocytes in the pathogenesis of neurodevelopmental disorders. Astrocytes undergo a dramatic maturation process following early differentiation from which typical morphology and important functions are acquired. Despite significant progress in understanding their early differentiation, very little is known about how astrocytes become functionally mature. In addition, whether functional maturation of astrocytes is disrupted in neurodevelopmental disorders and the consequences of this disruption remains essentially unknown. In this review, we discuss our perspectives about how astrocyte developmental maturation is regulated, and how disruption of the astrocyte functional maturation process, especially alterations in their ability to regulate glutamate homeostasis, may alter synaptic physiology and contribute to the pathogenesis of neurodevelopmental disorders.

Available only for authorised users

Diagnostic and statistical manual of mental disorders. 1994, Washington, DC: American Psychiatric Association, 4

Wassink TH, Brzustowicz LM, Bartlett CW, Szatmari P: The search for autism disease genes. Ment Retard Dev Disabil Res Rev. 2004, 10: 272-283. 10.1002/mrdd.20041.PubMed

Li X, Zou H, Brown WT: Genes associated with autism spectrum disorder. Brain Res Bull. 2012, 88: 543-552. 10.1016/j.brainresbull.2012.05.017.PubMed

Weiss LA, Arking DE, Daly MJ, Chakravarti A: A genome-wide linkage and association scan reveals novel loci for autism. Nature. 2009, 461: 802-808. 10.1038/nature08490.PubMedCentralPubMed

Luo R, Sanders SJ, Tian Y, Voineagu I, Huang N, Chu SH, Klei L, Cai C, Ou J, Lowe JK, Hurles ME, Devlin B, State MW, Geschwind DH: Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders. Am J Hum Genet. 2012, 91: 38-55. 10.1016/j.ajhg.2012.05.011.PubMedCentralPubMed

Michaelson JJ, Shi Y, Gujral M, Zheng H, Malhotra D, Jin X, Jian M, Liu G, Greer D, Bhandari A, Wu W, Corominas R, Peoples A, Koren A, Gore A, Kang S, Lin GN, Estabillo J, Gadomski T, Singh B, Zhang K, Akshoomoff N, Corsello C, McCarroll S, Iakoucheva LM, Li Y, Wang J, Sebat J: Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell. 2012, 151: 1431-1442. 10.1016/j.cell.2012.11.019.PubMedCentralPubMed

O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, Carvill G, Kumar A, Lee C, Ankenman K, Munson J, Hiatt JB, Turner EH, Levy R, O’Day DR, Krumm N, Coe BP, Martin BK, Borenstein E, Nickerson DA, Mefford HC, Doherty D, Akey JM, Bernier R, Eichler EE, Shendure J: Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science. 2012, 338: 1619-1622. 10.1126/science.1227764.PubMedCentralPubMed

O’Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, Ko A, Lee C, Smith JD, Turner EH, Stanaway IB, Vernot B, Malig M, Baker C, Reilly B, Akey JM, Borenstein E, Rieder MJ, Nickerson DA, Bernier R, Shendure J, Eichler EE: Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012, 485: 246-250. 10.1038/nature10989.PubMedCentralPubMed

Williams SC: Genetics: Searching for answers. Nature. 2012, 491: S4-S6. 10.1038/491S4a.PubMed

10.

Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999, 23: 185-188. 10.1038/13810.PubMed

11.

Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, Eussen BE, van Ommen G-JB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST: Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991, 65: 905-914. 10.1016/0092-8674(91)90397-H.PubMed

12.

Percy AK: Rett syndrome: exploring the autism link. Arch Neurol. 2011, 68: 985-989. 10.1001/archneurol.2011.149.PubMedCentralPubMed

13.

Oddi D, Crusio WE, D’Amato FR, Pietropaolo S: Monogenic mouse models of social dysfunction: Implications for autism. Behav Brain Res. 2013, 251: 75-84.PubMed

14.

DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, Schultz RT, Crawley J, Young LJ: The developmental neurobiology of autism spectrum disorder. J Neurosci. 2006, 26: 6897-6906. 10.1523/JNEUROSCI.1712-06.2006.PubMed

15.

Silver WG, Rapin I: Neurobiological basis of autism. Pediatr Clin North Am. 2012, 59: 45-61. 10.1016/j.pcl.2011.10.010. xPubMed

16.

McGann JC, Lioy DT, Mandel G: Astrocytes conspire with neurons during progression of neurological disease. Curr Opin Neurobiol. 2012, 22: 850-858. 10.1016/j.conb.2012.03.009.PubMedCentralPubMed

17.

Molofsky AV, Krencik R, Ullian EM, Tsai HH, Deneen B, Richardson WD, Barres BA, Rowitch DH: Astrocytes and disease: a neurodevelopmental perspective. Genes Dev. 2012, 26: 891-907. 10.1101/gad.188326.112.PubMedCentralPubMed

18.

Allen NJ, Bennett ML, Foo LC, Wang GX, Chakraborty C, Smith SJ, Barres BA: Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature. 2012, 486: 410-414.PubMedCentralPubMed

19.

Liauw J, Hoang S, Choi M, Eroglu C, Sun GH, Percy M, Wildman-Tobriner B, Bliss T, Guzman RG, Barres BA, Steinberg GK: Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab. 2008, 28: 1722-1732. 10.1038/jcbfm.2008.65.PubMed

20.

Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA: The classical complement cascade mediates CNS synapse elimination. Cell. 2007, 131: 1164-1178. 10.1016/j.cell.2007.10.036.PubMed

21.

Allen NJ, Barres BA: Neuroscience: Glia - more than just brain glue. Nature. 2009, 457: 675-677. 10.1038/457675a.PubMed

22.

Barres BA: The mystery and magic of glia: a perspective on their roles in health and disease. Neuron. 2008, 60: 430-440. 10.1016/j.neuron.2008.10.013.PubMed

23.

Tien AC, Tsai HH, Molofsky AV, McMahon M, Foo LC, Kaul A, Dougherty JD, Heintz N, Gutmann DH, Barres BA, Rowitch DH: Regulated temporal-spatial astrocyte precursor cell proliferation involves BRAF signalling in mammalian spinal cord. Development. 2012, 139: 2477-2487. 10.1242/dev.077214.PubMedCentralPubMed

24.

Sauvageot CM, Stiles CD: Molecular mechanisms controlling cortical gliogenesis. Curr Opin Neurobiol. 2002, 12: 244-249. 10.1016/S0959-4388(02)00322-7.PubMed

25.

Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, Stahl N, Yancopoulos GD, Greenberg ME: Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science. 1997, 278: 477-483. 10.1126/science.278.5337.477.PubMed

26.

Stipursky J, Francis D, Gomes FC: Activation of MAPK/PI3K/SMAD pathways by TGF-beta(1) controls differentiation of radial glia into astrocytes in vitro. Dev Neurosci. 2012, 34: 68-81. 10.1159/000338108.PubMed

27.

Nakashima K, Takizawa T, Ochiai W, Yanagisawa M, Hisatsune T, Nakafuku M, Miyazono K, Kishimoto T, Kageyama R, Taga T: BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc Natl Acad Sci U S A. 2001, 98: 5868-5873. 10.1073/pnas.101109698.PubMedCentralPubMed

28.

Nagao M, Sugimori M, Nakafuku M: Cross talk between notch and growth factor/cytokine signaling pathways in neural stem cells. Mol Cell Biol. 2007, 27: 3982-3994. 10.1128/MCB.00170-07.PubMedCentralPubMed

29.

Deneen B, Ho R, Lukaszewicz A, Hochstim CJ, Gronostajski RM, Anderson DJ: The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord. Neuron. 2006, 52: 953-968. 10.1016/j.neuron.2006.11.019.PubMed

30.

Barnabe-Heider F, Wasylnka JA, Fernandes KJ, Porsche C, Sendtner M, Kaplan DR, Miller FD: Evidence that embryonic neurons regulate the onset of cortical gliogenesis via cardiotrophin-1. Neuron. 2005, 48: 253-265. 10.1016/j.neuron.2005.08.037.PubMed

31.

Freeman MR: Specification and morphogenesis of astrocytes. Science. 2010, 330: 774-778. 10.1126/science.1190928.PubMed

32.

Song MR, Ghosh A: FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation. Nat Neurosci. 2004, 7: 229-235. 10.1038/nn1192.PubMed

33.

Stipursky J, Gomes FC: TGF-beta1/SMAD signaling induces astrocyte fate commitment in vitro: implications for radial glia development. Glia. 2007, 55: 1023-1033. 10.1002/glia.20522.PubMed

34.

Raff MC, Miller RH, Noble M: A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature. 1983, 303: 390-396. 10.1038/303390a0.PubMed

35.

Rowitch DH, Kriegstein AR: Developmental genetics of vertebrate glial-cell specification. Nature. 2010, 468: 214-222. 10.1038/nature09611.PubMed

36.

Ge WP, Miyawaki A, Gage FH, Jan YN, Jan LY: Local generation of glia is a major astrocyte source in postnatal cortex. Nature. 2012, 484: 376-380. 10.1038/nature10959.PubMedCentralPubMed

37.

Bushong EA, Martone ME, Jones YZ, Ellisman MH: Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci. 2002, 22: 183-192.PubMed

38.

Derouiche A, Frotscher M: Peripheral astrocyte processes: monitoring by selective immunostaining for the actin-binding ERM proteins. Glia. 2001, 36: 330-341. 10.1002/glia.1120.PubMed

39.

Wolff JR: The astrocyte as link between capillary and nerve cell. Triangle. 1970, 9: 153-164.PubMed

40.

Chao TI RM, Wolff JR: The synapse-astrocyte boundary: anatomical basis for an integrative role of glia in synaptic transmission. Tripartite synapses: Synaptic transmission with glia. Edited by: Volterra A, Magistretti P, Haydon PG. 2002, Oxford, New York: Oxford University Press

41.

Reichenbach AWH: Structural association of astrocytes with neurons and vasculature: defining territorial boundaries. Astrocytes in (patho)physiology of the nervous system. Edited by: Parpura VHP. 2009, New York: Springer, 251-286.

42.

Bandeira F, Lent R, Herculano-Houzel S: Changing numbers of neuronal and non-neuronal cells underlie postnatal brain growth in the rat. Proc Natl Acad Sci U S A. 2009, 106: 14108-14113. 10.1073/pnas.0804650106.PubMedCentralPubMed

43.

Bushong EA, Martone ME, Ellisman MH: Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development. Int J Dev Neurosci. 2004, 22: 73-86. 10.1016/j.ijdevneu.2003.12.008.PubMed

44.

Furuta A, Rothstein JD, Martin LJ: Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J Neurosci. 1997, 17: 8363-8375.PubMed

45.

Sutherland ML, Delaney TA, Noebels JL: Glutamate transporter mRNA expression in proliferative zones of the developing and adult murine CNS. J Neurosci. 1996, 16: 2191-2207.PubMed

46.

Nagy JI, Patel D, Ochalski PA, Stelmack GL: Connexin30 in rodent, cat and human brain: selective expression in gray matter astrocytes, co-localization with connexin43 at gap junctions and late developmental appearance. Neuroscience. 1999, 88: 447-468. 10.1016/S0306-4522(98)00191-2.PubMed

47.

Seifert G, Huttmann K, Binder DK, Hartmann C, Wyczynski A, Neusch C, Steinhauser C: Analysis of astroglial K+ channel expression in the developing hippocampus reveals a predominant role of the Kir4.1 subunit. J Neurosci. 2009, 29: 7474-7488. 10.1523/JNEUROSCI.3790-08.2009.PubMed

48.

Higashimori H, Sontheimer H: Role of Kir4.1 channels in growth control of glia. Glia. 2007, 55: 1668-1679. 10.1002/glia.20574.PubMedCentralPubMed

49.

Schlag BD, Vondrasek JR, Munir M, Kalandadze A, Zelenaia OA, Rothstein JD, Robinson MB: Regulation of the glial Na+−dependent glutamate transporters by cyclic AMP analogs and neurons. Mol Pharmacol. 1998, 53: 355-369.PubMed

50.

Duan S, Anderson CM, Stein BA, Swanson RA: Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci. 1999, 19: 10193-10200.PubMed

51.

Yang Y, Gozen O, Watkins A, Lorenzini I, Lepore A, Gao Y, Vidensky S, Brennan J, Poulsen D, Won Park J, Li Jeon N, Robinson MB, Rothstein JD: Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1. Neuron. 2009, 61: 880-894. 10.1016/j.neuron.2009.02.010.PubMedCentralPubMed

52.

Swanson RA, Liu J, Miller JW, Rothstein JD, Farrell K, Stein BA, Longuemare MC: Neuronal regulation of glutamate transporter subtype expression in astrocytes. J Neurosci. 1997, 17: 932-940.PubMed

53.

Koulakoff A, Ezan P, Giaume C: Neurons control the expression of connexin 30 and connexin 43 in mouse cortical astrocytes. Glia. 2008, 56: 1299-1311. 10.1002/glia.20698.PubMed

54.

Rouach N, Glowinski J, Giaume C: Activity-dependent neuronal control of gap-junctional communication in astrocytes. J Cell Biol. 2000, 149: 1513-1526. 10.1083/jcb.149.7.1513.PubMedCentralPubMed

55.

Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA: A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci. 2008, 28: 264-278. 10.1523/JNEUROSCI.4178-07.2008.PubMed

56.

Lovatt D, Sonnewald U, Waagepetersen HS, Schousboe A, He W, Lin JH, Han X, Takano T, Wang S, Sim FJ, Goldman SA, Nedergaard M: The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J Neurosci. 2007, 27: 12255-12266. 10.1523/JNEUROSCI.3404-07.2007.PubMed

57.

Agulhon C, Petravicz J, McMullen AB, Sweger EJ, Minton SK, Taves SR, Casper KB, Fiacco TA, McCarthy KD: What is the role of astrocyte calcium in neurophysiology?. Neuron. 2008, 59: 932-946. 10.1016/j.neuron.2008.09.004.PubMedCentralPubMed

58.

Wang X, Lou N, Xu Q, Tian GF, Peng WG, Han X, Kang J, Takano T, Nedergaard M: Astrocytic Ca2+ signaling evoked by sensory stimulation in vivo. Nat Neurosci. 2006, 9: 816-823. 10.1038/nn1703.PubMed

59.

Sun W, McConnell E, Pare JF, Xu Q, Chen M, Peng W, Lovatt D, Han X, Smith Y, Nedergaard M: Glutamate-dependent neuroglial calcium signaling differs between young and adult brain. Science. 2013, 339: 197-200. 10.1126/science.1226740.PubMedCentralPubMed

60.

Lavialle M, Aumann G, Anlauf E, Prols F, Arpin M, Derouiche A: Structural plasticity of perisynaptic astrocyte processes involves ezrin and metabotropic glutamate receptors. Proc Natl Acad Sci U S A. 2011, 108: 12915-12919. 10.1073/pnas.1100957108.PubMedCentralPubMed

61.

Genoud C, Quairiaux C, Steiner P, Hirling H, Welker E, Knott GW: Plasticity of astrocytic coverage and glutamate transporter expression in adult mouse cortex. PLoS Biol. 2006, 4: e343-10.1371/journal.pbio.0040343.PubMedCentralPubMed

62.

Eiraku M, Tohgo A, Ono K, Kaneko M, Fujishima K, Hirano T, Kengaku M: DNER acts as a neuron-specific Notch ligand during Bergmann glial development. Nat Neurosci. 2005, 8: 873-880. 10.1038/nn1492.PubMed

63.

Laurence JA, Fatemi SH: Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum. 2005, 4: 206-210. 10.1080/14734220500208846.PubMed

64.

Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J: Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology. 2001, 57: 1618-1628. 10.1212/WNL.57.9.1618.PubMed

65.

Fatemi SH, Folsom TD, Reutiman TJ, Lee S: Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism. Synapse. 2008, 62: 501-507. 10.1002/syn.20519.PubMedCentralPubMed

66.

Gadow KD, Roohi J, DeVincent CJ, Kirsch S, Hatchwell E: Glutamate transporter gene (SLC1A1) single nucleotide polymorphism (rs301430) and repetitive behaviors and anxiety in children with autism spectrum disorder. J Autism Dev Disord. 2010, 40: 1139-1145. 10.1007/s10803-010-0961-7.PubMedCentralPubMed

67.

Sicca F, Imbrici P, D’Adamo MC, Moro F, Bonatti F, Brovedani P, Grottesi A, Guerrini R, Masi G, Santorelli FM, Pessia M: Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1. Neurobiol Dis. 2011, 43: 239-247. 10.1016/j.nbd.2011.03.016.PubMed

68.

Guy J, Hendrich B, Holmes M, Martin JE, Bird A: A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet. 2001, 27: 322-326. 10.1038/85899.PubMed

69.

Chen RZ, Akbarian S, Tudor M, Jaenisch R: Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet. 2001, 27: 327-331. 10.1038/85906.PubMed

70.

Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell. 1994, 78: 23-33.

71.

Zoghbi HY: Postnatal neurodevelopmental disorders: meeting at the synapse?. Science. 2003, 302: 826-830. 10.1126/science.1089071.PubMed

72.

Bear MF, Huber KM, Warren ST: The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004, 27: 370-377. 10.1016/j.tins.2004.04.009.PubMed

73.

Ballas N, Lioy DT, Grunseich C, Mandel G: Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci. 2009, 12: 311-317. 10.1038/nn.2275.PubMedCentralPubMed

74.

Jacobs S, Nathwani M, Doering LC: Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression. BMC Neurosci. 2010, 11: 132-10.1186/1471-2202-11-132.PubMedCentralPubMed

75.

Jacobs S, Doering LC: Astrocytes prevent abnormal neuronal development in the fragile x mouse. J Neurosci. 2010, 30: 4508-4514. 10.1523/JNEUROSCI.5027-09.2010.PubMed

76.

Yang Q, Feng B, Zhang K, Guo YY, Liu SB, Wu YM, Li XQ, Zhao MG: Excessive astrocyte-derived neurotrophin-3 contributes to the abnormal neuronal dendritic development in a mouse model of fragile x syndrome. PLoS Genet. 2012, 8: e1003172-10.1371/journal.pgen.1003172.PubMedCentralPubMed

77.

Maezawa I, Swanberg S, Harvey D, LaSalle JM, Jin LW: Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci. 2009, 29: 5051-5061. 10.1523/JNEUROSCI.0324-09.2009.PubMedCentralPubMed

78.

Okabe Y, Takahashi T, Mitsumasu C, Kosai K, Tanaka E, Matsuishi T: Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. PLoS One. 2012, 7: e35354-10.1371/journal.pone.0035354.PubMedCentralPubMed

79.

Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK, Hirrlinger PG, Kirchhoff F, Bissonnette JM, Ballas N, Mandel G: A role for glia in the progression of Rett’s syndrome. Nature. 2011, 475: 497-500. 10.1038/nature10214.PubMedCentralPubMed

80.

Manent JB, Represa A: Neurotransmitters and brain maturation: early paracrine actions of GABA and glutamate modulate neuronal migration. Neuroscientist. 2007, 13: 268-279. 10.1177/1073858406298918.PubMed

81.

Matsugami TR, Tanemura K, Mieda M, Nakatomi R, Yamada K, Kondo T, Ogawa M, Obata K, Watanabe M, Hashikawa T, Tanaka K: From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development. Proc Natl Acad Sci U S A. 2006, 103: 12161-12166. 10.1073/pnas.0509144103.PubMedCentralPubMed

82.

Choudhury PR, Lahiri S, Rajamma U: Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacol Biochem Behav. 2012, 100: 841-849. 10.1016/j.pbb.2011.06.023.PubMed

83.

Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B, Gillberg C, Leboyer M, Bourgeron T: Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry. 2002, 7: 302-310. 10.1038/sj.mp.4000979.PubMedCentralPubMed

84.

Serajee FJ, Zhong H, Nabi R, Huq AH: The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J Med Genet. 2003, 40: e42-10.1136/jmg.40.4.e42.PubMedCentralPubMed

85.

Barnby G, Abbott A, Sykes N, Morris A, Weeks DE, Mott R, Lamb J, Bailey AJ, Monaco AP: Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT. Am J Hum Genet. 2005, 76: 950-966. 10.1086/430454.PubMedCentralPubMed

86.

Bassell GJ, Warren ST: Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron. 2008, 60: 201-214. 10.1016/j.neuron.2008.10.004.PubMedCentralPubMed

87.

Huber KM, Gallagher SM, Warren ST, Bear MF: Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A. 2002, 99: 7746-7750. 10.1073/pnas.122205699.PubMedCentralPubMed

88.

Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough WT: Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A. 1997, 94: 5401-5404. 10.1073/pnas.94.10.5401.PubMedCentralPubMed

89.

Hagerman PJ, Stafstrom CE: Origins of epilepsy in fragile X syndrome. Epilepsy Curr. 2009, 9: 108-112. 10.1111/j.1535-7511.2009.01309.x.PubMedCentralPubMed

90.

Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG, Jaeschke G, Bear MF, Lindemann L: Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron. 2012, 74: 49-56. 10.1016/j.neuron.2012.03.009.PubMed

91.

Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, Bear MF: Correction of fragile X syndrome in mice. Neuron. 2007, 56: 955-962. 10.1016/j.neuron.2007.12.001.PubMedCentralPubMed

92.

Silverman JL, Smith DG, Rizzo SJ, Karras MN, Turner SM, Tolu SS, Bryce DK, Smith DL, Fonseca K, Ring RH, Crawley JN: Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med. 2012, 4: 131ra151-

93.

Huang YH, Bergles DE: Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol. 2004, 14: 346-352. 10.1016/j.conb.2004.05.007.PubMed

94.

Danbolt NC: Glutamate uptake. ProgNeurobiol. 2001, 65: 1-105.

95.

Huang YH, Sinha SR, Tanaka K, Rothstein JD, Bergles DE: Astrocyte glutamate transporters regulate metabotropic glutamate receptor-mediated excitation of hippocampal interneurons. J Neurosci. 2004, 24: 4551-4559. 10.1523/JNEUROSCI.5217-03.2004.PubMed

96.

Omrani A, Melone M, Bellesi M, Safiulina V, Aida T, Tanaka K, Cherubini E, Conti F: Up-regulation of GLT-1 severely impairs LTD at mossy fibre–CA3 synapses. J Physiol. 2009, 587: 4575-4588. 10.1113/jphysiol.2009.177881.PubMedCentralPubMed

97.

Higashimori H, Morel L, Huth J, Lindemann L, Dulla C, Taylor A, Freeman M, Yang Y: Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X Mouse. Hum Mol Genet. 2013, 22: 2041-2054. 10.1093/hmg/ddt055.PubMedCentralPubMed

98.

Tanaka K: Epilepsy and exacerbation of brain injury in mice lacking glutamate transporter GLT-1 (Vol 276, pg 1699, 1997). Science. 1997, 278: 21-21.

99.

Takasaki C, Okada R, Mitani A, Fukaya M, Yamasaki M, Fujihara Y, Shirakawa T, Tanaka K, Watanabe M: Glutamate transporters regulate lesion-induced plasticity in the developing somatosensory cortex. J Neurosci. 2008, 28: 4995-5006. 10.1523/JNEUROSCI.0861-08.2008.PubMed

100.

Tanaka K: Role of glutamate transporters in the pathophysiology of major mental illnesses. Nihon Shinkei Seishin Yakurigaku Zasshi. 2009, 29: 161-164.PubMed

101.

Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, Lawler J, Mosher DF, Bornstein P, Barres BA: Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell. 2005, 120: 421-433. 10.1016/j.cell.2004.12.020.PubMed

102.

Kucukdereli H, Allen NJ, Lee AT, Feng A, Ozlu MI, Conatser LM, Chakraborty C, Workman G, Weaver M, Sage EH, Barres BA, Eroglu C: Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc Natl Acad Sci U S A. 2011, 108: E440-E449. 10.1073/pnas.1104977108.PubMedCentralPubMed

103.

Regan MR, Huang YH, Kim YS, Dykes-Hoberg MI, Jin L, Watkins AM, Bergles DE, Rothstein JD: Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS. J Neurosci. 2007, 27: 6607-6619. 10.1523/JNEUROSCI.0790-07.2007.PubMed

104.

Yang Y, Vidensky S, Jin L, Jie C, Lorenzini I, Frankl M, Rothstein JD: Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice. Glia. 2011, 59: 200-207. 10.1002/glia.21089.PubMedCentralPubMed

105.

Doyle JP, Dougherty JD, Heiman M, Schmidt EF, Stevens TR, Ma G, Bupp S, Shrestha P, Shah RD, Doughty ML, Gong S, Greengard P, Heintz N: Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell. 2008, 135: 749-762. 10.1016/j.cell.2008.10.029.PubMedCentralPubMed

106.

Heiman M, Schaefer A, Gong S, Peterson JD, Day M, Ramsey KE, Suarez-Farinas M, Schwarz C, Stephan DA, Surmeier DJ, Greenard P, Heintz N: A translational profiling approach for the molecular characterization of CNS cell types. Cell. 2008, 135: 738-748. 10.1016/j.cell.2008.10.028.PubMedCentralPubMed

Title: Developmental maturation of astrocytes and pathogenesis of neurodevelopmental disorders
Authors: Yongjie Yang
Haruki Higashimori
Lydie Morel
Publication date: 01-12-2013
Publisher: BioMed Central
Published in: Journal of Neurodevelopmental Disorders / Issue 1/2013
Print ISSN: 1866-1947
Electronic ISSN: 1866-1955
DOI: https://doi.org/10.1186/1866-1955-5-22

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Developmental maturation of astrocytes and pathogenesis of neurodevelopmental disorders

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2013

Resting state EEG abnormalities in autism spectrum disorders

A molecular genetic study of autism and related phenotypes in extended pedigrees

Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study

Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteins

Methotrexate treatment of FraX fibroblasts results in FMR1 transcription but not in detectable FMR1 protein levels

Sensory and motor secondary symptoms as indicators of brain vulnerability